BZAM Ltd. (CSE: BZAM) (US-OTC: BZAMF) is set to bring its pot overseas after signing a partnership with a medical cannabis distributor operating in the United Kingdom.
The company’s subsidiary The Green Organic Dutchman Ltd. announced Tuesday it signed a deal with United Kingdom-based medical cannabis distributor 4C LABS Ltd. to commercialize the products under TGOD’s brand. The company aims to start selling TGOD products starting in the last quarter of this year.
Under the agreement signed last month, BZAM will supply approximately 600 kilograms of flower annually for the next two years. The company carries organic flower and hash under its TGOD and Highly Dutch brands which are popular in Quebec and Ontario.
“We are extremely pleased to be able to offer The Green Organic Dutchman products to our UK patients,” 4C LABS CEO Greg Dobbin said.
“BZAM is a world-class company which operates a truly innovative facility where Canada’s best growers and unique genetics come together. From feeding certain plants maple syrup to creating community gardens at their grow facility, the BZAM team takes medical cannabis to the next level,” he added.
4C LABS Ltd. is a privately held medical cannabis company based in the UK. It focuses on providing patients with high-quality, affordable medical cannabis products. 4C LABS holds import and distribution licenses in the UK, as well as a broad network of pharmacies across the UK and Channel Islands.
Read more: TGOD enters deal to merge with BZAM Cannabis
BZAM was recently awarded Good Manufacturing Practice certification from the European Union for its greenhouse facility in Ancaster, Ontario, Canada. This certification allows the company to export selected medical cannabis products to many international markets, including the United Kingdom.
“We are proud to announce this agreement with 4C LABS to bring our exceptional product to the UK market. Executing on our recent EU GMP Certification is a key priority and we are excited to be able to partner with local experts like 4C LABS,” BZAM CEO Matt Milich said.
BZAM stock went up by 13.25 per cent on Tuesday to $0.25 on the Canadian Securities Exchange.